While the human genome project has been a significant development in the biotechnology sector, it wi...
While the human genome project has been a significant development in the biotechnology sector, it will be 10 years before it has real impact , according Colin Riddles, smaller companies fund manager at HSBC. He says: "The project is the current big issue and will create new earning streams, which is good news." At present there is only a limited amount of money to be made, as a minimal number of companies are using the project and only a handful of companies in the UK are involved in genomics, Riddles says. In the longer term this could be seen as a window of opportunity as there is room...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes